Clinigen Group PLC (LSE:CLIN) - Share price


Stock Report

Clinigen Group PLC CLIN

Last Price
GBX951.50

Day Change
28.00|3.03%

As of 20/09/2019
17:46:13 BST | GBX
Minimum 15 Minutes Delay.

Last Close923.50p
Day Range916.00 - 951.50
Mkt Cap1.22Bil
52-Wk Range716.00 - 1,069.00
Yield %0.66
ISINGB00B89J2419
Volume313,236
P/E44.25
P/S0.03
P/CF0.24

Share Price

Total Returns 19/09/2019

 Chg (%)  
More ...
Clinigen Group PLC2.16 
FTSE 100 TR GBP3.35
 
Financials
201620172018
More ...
Income Statement
Turnover339.90302.30381.20
Operating Profit42.7062.6071.80
Net Profit13.503.8027.40
Reported EPS11.803.2022.50
Balance Sheet
Current Assets112.20111.40153.50
Non Current Assets347.70348.10513.60
Total Assets459.90459.50667.10
Current Liabilities164.30134.80113.80
Total Liabilities---
Total Equity236.50249.10349.50
Cash Flow
Operating Cash Flow45.8053.0060.20
Net Change in Cash-0.60-0.508.80

Regulatory News

DateAuthor Headline
18/10/2017Samuel Meakin Why Smaller Companies Funds Have Outperformed
The average UK smaller companies fund has comfortably outperformed the FTSE Small Cap and Numis Smaller Companies indices in 2017 so far
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
19/09/2019PurchaseMr. Nicholas Patrick Keher893.003,90034,827.00
01/10/2018PurchaseMs Anne Philomena Hyland845.004,14235,000.00
01/10/2018PurchaseShaun Edward Chilton845.007,10160,003.00

Company Profile

Clinigen Group PLC is engaged in pharmaceutical and services business. It provides its services to patients, the medical community and the healthcare industry.

Sector

Medical Distribution

Index

FTSE AIM UK 50 ,FTSE AIM 100 ,FTSE AIM All-Share

Next Event 09/10/2019

Annual Report
Ratios
Comp
More ...
PER (E)44.25
Div Yld (E)0.65
PEG (E)0.00
ROCE7.30
Op Mrgn0.19
EPS Grwth1.81
Dividends
PreviousLatest
More ...
Record Date22/03/1908/11/19
Ex-Div21/03/1907/11/19
Paid12/04/1929/11/19
Amnt1.954.75
Directors
More ...
Non-Executive DirectorMs Anne Philomena Hyland
Non-Executive Director, ChairmanMr. Peter Vance Allen
Non-Executive DirectorMr. Ian James Nicholson
Non-Executive DirectorMr. John Hartup
Executive Director, Chief Executive OfficerShaun Edward Chilton
Executive DirectorMr. Nicholas Patrick Keher
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.